ArticleMolecular cancer therapeutics2008

Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor.

Adriana S Beltran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.